Category Archives: Prescription Drugs

Competition in Medicare Advantage, Part D, and “Extra Help”/ Working together for seniors and taxpayers

Seniors are beginning to get fliers in the mail alerting them to the upcoming open season for enrollment in Medicare Advantage and Medicare Part D prescription drug plans.  Both programs rely on competition and consumer choice to increase options and hold down costs for seniors.  Open season begins October 15 for those planning to enroll […]

Read More

More Competition is the Best Cure

The most interesting thing about the PR disaster involving Mylan’s life-saving EpiPen is probably the least discussed—namely that drugs don’t cost what people think they do. Faced with a barrage of criticism for EpiPen price hikes, from about $100 in 2009 to more than $600 today, Mylan’s CEO Heather Bresch explains that her company gets less than […]

Read More

Poll study top page

In A Politically Polarized Year, Poll Finds Wide Agreement Among Voters On A Key Health Care Agenda

A new poll of voters in battleground states finds a rare opportunity for bipartisan agreement on health care, with Americans strongly favoring action on public policies that support medical discovery into new treatments and cures. The poll was jointly commissioned by the Galen Institute and Center Forward, center-right and center-left think tanks. Purple Insights interviewed 800 registered […]

Read More

Prescription drug price controls pose lethal problems

The Democratic primaries may be contentious, but both candidates agree on one point: government fiat must rein in prescription drug prices. Hillary Clinton proposes caps on drug prices and a mandate that pharmaceutical companies spend a preset percentage of revenues on research and development. She’d confiscate any excess to subsidize public biomedical research institutions like […]

Read More